• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼移植物抗宿主病的最新进展。

Update on ocular graft-versus-host disease.

机构信息

Cornea, Cataract & Refractive Surgery Services, Dr R P Centre, All India Institute of Medical Sciences, New Delhi, India.

Department of Ophthalmology, University of Chicago, USA.

出版信息

Indian J Ophthalmol. 2021 May;69(5):1038-1050. doi: 10.4103/ijo.IJO_2016_20.

DOI:10.4103/ijo.IJO_2016_20
PMID:33913829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8186644/
Abstract

Ocular graft-versus-host disease (oGVHD) occurs as a complication following hematopoietic stem cell transplantation and is associated with significant ocular morbidity resulting in a marked reduction in the quality of life. With no current consensus on treatment protocols, management becomes challenging as recurrent oGVHD often refractory to conventional treatment. Most authors now diagnose and grade the disease based on criteria provided by the National Institutes of Health Consensus Conference (NIH CC) or the International Chronic oGVHD (ICCGVHD) consensus group. This article will provide an insight into the diagnostic criteria of oGVHD, its classification, and clinical severity grading scales. The inflammatory process in oGVHD can involve the entire ocular surface including the eyelids, meibomian gland, corneal, conjunctiva, and lacrimal system. The varied clinical presentations and treatment strategies employed to manage them have been discussed in the present study. The recent advances in ocular surface imaging in oGVHD patients such as the use of meibography and in vivo confocal microscopy may help in early diagnosis and prognostication of the disease. Researching tear proteomics and identification of novel potential tear biomarkers in oGVHD patients is an exciting field as they may help in objectively diagnosing the disease and monitoring the response to treatment.

摘要

眼移植物抗宿主病(oGVHD)是造血干细胞移植后的一种并发症,与显著的眼部发病率相关,导致生活质量显著下降。由于复发性 oGVHD 通常对常规治疗有抗性,因此目前尚无治疗方案的共识,这使得管理变得具有挑战性。大多数作者现在根据美国国立卫生研究院共识会议(NIH CC)或国际慢性 oGVHD(ICCGVHD)共识小组提供的标准来诊断和分级该疾病。本文将深入了解 oGVHD 的诊断标准、分类和临床严重程度分级量表。oGVHD 的炎症过程可累及整个眼表面,包括眼睑、睑板腺、角膜、结膜和泪液系统。本研究讨论了它们的不同临床表现和治疗策略。oGVHD 患者在眼表面成像方面的最新进展,如使用睑板腺成像和共聚焦显微镜,可能有助于早期诊断和预测疾病。研究 oGVHD 患者的泪液蛋白质组学和鉴定新的潜在泪液生物标志物是一个令人兴奋的领域,因为它们可能有助于客观诊断疾病并监测治疗反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d60/8186644/09e5e9e22a0f/IJO-69-1038-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d60/8186644/391b6f00f940/IJO-69-1038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d60/8186644/4e93fbdfcfde/IJO-69-1038-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d60/8186644/09e5e9e22a0f/IJO-69-1038-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d60/8186644/391b6f00f940/IJO-69-1038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d60/8186644/4e93fbdfcfde/IJO-69-1038-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d60/8186644/09e5e9e22a0f/IJO-69-1038-g003.jpg

相似文献

1
Update on ocular graft-versus-host disease.眼移植物抗宿主病的最新进展。
Indian J Ophthalmol. 2021 May;69(5):1038-1050. doi: 10.4103/ijo.IJO_2016_20.
2
A brief account on ocular graft versus host disease.眼移植物抗宿主病简述。
Indian J Ophthalmol. 2023 Apr;71(4):1115-1122. doi: 10.4103/IJO.IJO_2839_22.
3
How does ocular graft-versus-host disease fit under the dry eye umbrella? A review.眼部移植物抗宿主病如何归入干眼范畴?一篇综述。
Clin Exp Ophthalmol. 2024 Mar;52(2):167-185. doi: 10.1111/ceo.14347. Epub 2024 Jan 10.
4
Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients.异基因造血干细胞移植患者的眼表评估
Eur J Ophthalmol. 2014 Sep-Oct;24(5):655-66. doi: 10.5301/ejo.5000451. Epub 2014 Mar 7.
5
Ocular graft-versus-host disease (oGVHD): From A to Z.眼移植物抗宿主病(oGVHD):从 A 到 Z。
Surv Ophthalmol. 2023 Jul-Aug;68(4):697-712. doi: 10.1016/j.survophthal.2023.02.006. Epub 2023 Mar 2.
6
Tear Film Immunological Profile in Patients with Ocular Graft versus Host Disease.眼移植物抗宿主病患者的泪膜免疫特征。
Ocul Immunol Inflamm. 2023 May;31(4):701-709. doi: 10.1080/09273948.2022.2046794. Epub 2022 Apr 11.
7
Risk factors for the development of ocular graft-versus-host disease (GVHD) dry eye syndrome in patients with chronic GVHD.慢性移植物抗宿主病(GVHD)患者发生眼部移植物抗宿主病(GVHD)干眼综合征的危险因素。
Br J Ophthalmol. 2015 Nov;99(11):1514-8. doi: 10.1136/bjophthalmol-2014-306438. Epub 2015 May 6.
8
A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit.多学科眼移植物抗宿主病单位中的大量眼部表面表现。
Sci Rep. 2022 Sep 23;12(1):15926. doi: 10.1038/s41598-022-19990-z.
9
Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation.异基因干细胞移植而未行全身照射后的眼部表现和眼部移植物抗宿主病。
Bone Marrow Transplant. 2018 Jul;53(7):863-872. doi: 10.1038/s41409-018-0090-z. Epub 2018 Jan 30.
10
Prevalence of neurotrophic keratopathy in patients with chronic ocular graft-versus-host disease.慢性眼部移植物抗宿主病患者的神经营养性角膜病变患病率。
Ocul Surf. 2022 Oct;26:13-18. doi: 10.1016/j.jtos.2022.07.001. Epub 2022 Jul 16.

引用本文的文献

1
Role of Topical Insulin in Severe Ocular Graft-Versus-Host Disease With Acute Bilateral Perforation.局部胰岛素在伴有急性双侧穿孔的严重眼部移植物抗宿主病中的作用
Cureus. 2025 Jun 6;17(6):e85468. doi: 10.7759/cureus.85468. eCollection 2025 Jun.
2
Understanding the immunology of the ocular surface and its relevance to clinical practice.了解眼表免疫学及其与临床实践的相关性。
Indian J Ophthalmol. 2025 Apr 1;73(4):516-520. doi: 10.4103/IJO.IJO_1721_24. Epub 2025 Mar 27.
3
Assessment of Survivorship in Allogeneic Hematopoietic Stem Cell Transplantation.

本文引用的文献

1
Self-retained cryopreserved amniotic membrane in treating acute ocular graft-versus-host-disease (oGVHD).自体保存的冷冻羊膜治疗急性眼部移植物抗宿主病(oGVHD)。
Am J Ophthalmol Case Rep. 2020 May 31;19:100761. doi: 10.1016/j.ajoc.2020.100761. eCollection 2020 Sep.
2
Advances in the diagnosis and treatment of dry eye.干眼症诊断与治疗的进展
Prog Retin Eye Res. 2020 Jan 29:100842. doi: 10.1016/j.preteyeres.2020.100842.
3
Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD).
异基因造血干细胞移植中生存情况的评估
Methods Mol Biol. 2025;2907:91-125. doi: 10.1007/978-1-0716-4430-0_5.
4
Application of lacrimal gland ultrasonography in the evaluation of chronic ocular graft-versus-host-disease.泪腺超声检查在慢性眼部移植物抗宿主病评估中的应用
Front Immunol. 2025 Feb 5;16:1490390. doi: 10.3389/fimmu.2025.1490390. eCollection 2025.
5
Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host Disease.使用JAK激酶抑制剂巴瑞替尼进行全身治疗在眼部慢性移植物抗宿主病中的应用
Ophthalmol Sci. 2024 Sep 30;5(1):100627. doi: 10.1016/j.xops.2024.100627. eCollection 2025 Jan-Feb.
6
Umbilical Cord Blood Platelet Lysate Eyedrops for the Treatment of Severe Ocular Surface Disorders in Graft vs. Host Disease Patients: Clinical Study.脐带血血小板裂解液滴眼液治疗移植物抗宿主病患者严重眼表疾病的临床研究
Life (Basel). 2024 Oct 5;14(10):1268. doi: 10.3390/life14101268.
7
Chronic Ocular GVHD Treatment at Two Locations of a Tertiary Referral Center.三级转诊中心两个地点的慢性眼部移植物抗宿主病治疗
Clin Ophthalmol. 2024 Sep 30;18:2731-2739. doi: 10.2147/OPTH.S463526. eCollection 2024.
8
Clinical Manifestations and Outcomes of Ocular Graft Versus Host Disease following Allogeneic Stem Cell Transplantation.异基因干细胞移植后眼部移植物抗宿主病的临床表现及结局
J Ophthalmic Vis Res. 2024 Sep 16;19(3):284-296. doi: 10.18502/jovr.v19i3.13095. eCollection 2024 Jul-Sep.
9
Epidemiology and risk factors for the development of cicatrizing conjunctivitis in chronic ocular graft-versus-host disease.慢性眼部移植物抗宿主病中瘢痕性结膜炎发生的流行病学及危险因素
Ocul Surf. 2024 Oct;34:341-347. doi: 10.1016/j.jtos.2024.09.002. Epub 2024 Sep 12.
10
"Window of Opportunity" in Ocular Graft-Versus-Host Disease Treatment: Results of a Longitudinal Study and Case Reports.眼部移植物抗宿主病治疗中的“机会窗”:一项纵向研究及病例报告结果
Eye Contact Lens. 2024 May 1;50(5):222-232. doi: 10.1097/ICL.0000000000001081. Epub 2024 Mar 13.
眼慢性移植物抗宿主病(GVHD)的诊断和严重程度评估中的泪液细胞因子水平。
Ocul Surf. 2020 Apr;18(2):298-304. doi: 10.1016/j.jtos.2019.12.005. Epub 2020 Jan 15.
4
Assessment of Corneal Fluorescein Staining in Different Dry Eye Subtypes Using Digital Image Analysis.使用数字图像分析评估不同干眼亚型中的角膜荧光素染色
Transl Vis Sci Technol. 2019 Dec 12;8(6):34. doi: 10.1167/tvst.8.6.34. eCollection 2019 Nov.
5
Pathological consequences of anti-citrullinated protein antibodies in tear fluid and therapeutic potential of pooled human immune globulin-eye drops in dry eye disease.抗瓜氨酸化蛋白抗体在泪液中的病理后果及人免疫球蛋白滴眼剂治疗干眼症的潜在作用。
Ocul Surf. 2020 Jan;18(1):80-97. doi: 10.1016/j.jtos.2019.10.004. Epub 2019 Oct 10.
6
Corneal higher-order aberrations in eyes with chronic ocular graft-versus-host disease.慢性眼部移植物抗宿主病患者眼睛的角膜高阶像差
Ocul Surf. 2020 Jan;18(1):98-107. doi: 10.1016/j.jtos.2019.10.005. Epub 2019 Oct 9.
7
A Phase I/II Placebo-Controlled Randomized Pilot Clinical Trial of Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients With Dry Eye Disease.重组脱氧核糖核酸酶(DNase)滴眼液用于干眼症患者的I/II期安慰剂对照随机试验性临床试验
Transl Vis Sci Technol. 2019 May 2;8(3):10. doi: 10.1167/tvst.8.3.10. eCollection 2019 May.
8
Longitudinal analysis of meibomian gland dropout in patients with ocular graft-versus-host disease.眼移植物抗宿主病患者的睑板腺缺失的纵向分析。
Ocul Surf. 2019 Jul;17(3):464-469. doi: 10.1016/j.jtos.2019.04.009. Epub 2019 Apr 20.
9
Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: Implications for novel biomarkers and therapeutic strategies.中性粒细胞胞外诱捕网(NETs)参与眼部移植物抗宿主病(oGVHD)干眼的病理变化:对新型生物标志物和治疗策略的启示。
Ocul Surf. 2019 Jul;17(3):589-614. doi: 10.1016/j.jtos.2019.03.010. Epub 2019 Apr 6.
10
Comparison of the meibomian gland dysfunction in patients with chronic ocular graft-versus-host disease and Sjögren's syndrome.慢性眼部移植物抗宿主病与干燥综合征患者睑板腺功能障碍的比较。
Int J Ophthalmol. 2019 Mar 18;12(3):393-400. doi: 10.18240/ijo.2019.03.07. eCollection 2019.